The Latest Breaking News from FDA

Mifepristone is under scrutiny in the courts, but it has been used safely and effectively around the world for decades

A flurry of court rulings in April 2023 has left the future of the abortion pill mifepristone in question. For now, a U.S. Supreme Court decision on April 21 allows the drug to remain accessible without additional restrictions as the merits of the case are weighed in lower court proceedings.

The Conversation · Apr 26, 2023

Most melatonin gummies have higher doses than what's on the label

A new analysis reveals that most melatonin gummies sold in the U.S. contain more of the hormone than noted on their labels.

LiveScience · Apr 26, 2023

Father reveals reason why he shared hospital photo of son who died in ‘TikTok Benadryl challenge’

Jacob Stevens, 13, died six days after attempting the deadly challenge

The Independent UK · Apr 25, 2023

This Company Is Solving A $1B Problem, And It’s Creating An Opportunity For Investors

One of the largest burdens faced by people over 50 is spinal discomfort. Dymicron invented an option poised to help patients in need of a breakthrough – representing a $1B potential addressable market. For a limited time, the company is taking investors to help share their innovation with the world.

Kiplinger · Apr 24, 2023

What is the TikTok Benadryl challenge that left a 13-year-old dead?

The dangerous challenge first circulated on social media in 2020, prompting the US’s Food and Drug Administration to issue a warning

Evening Standard · Apr 24, 2023

Majority of Americans oppose bans of medication abortion drugs, poll finds

Majority of Americans also don’t believe federal judges should be able to overturn FDA approval of a prescription drug, poll shows

The Guardian - US · Apr 24, 2023

Belgium Destroys Thousands of Miller High Life Cans Over 'Champagne of Beers' Slogan

Plus: No one is excited about a 2024 rematch between Biden and Trump, it's showtime for House Republicans' debt ceiling bill, and more...

Reason · Apr 24, 2023

How will the Supreme Court's decision on mifepristone affect abortion access? 4 questions answered

On April 21, 2023, the U.S. Supreme Court ruled that the abortion pill mifepristone, which is used in more than half of all abortions in the U.S., could remain accessible without restrictions – at least for now. The decision is temporary, however, buying time as an appeals court weighs the…

The Conversation · Apr 24, 2023

Poll: Two-thirds oppose banning medication abortion

A new NPR/PBS NewsHour/Marist poll finds 64% oppose laws that ban medication abortion — and confidence in the Supreme Court hits a new low.

WEKU · Apr 24, 2023

Emergency Contraception Should Be a Basic Component of Women’s Reproductive Health Care

Emergency contraception can take the form of pills – sometimes called the morning-after pill – or an intrauterine device, or IUD that delays ovulation.

Inverse · Apr 23, 2023